Post on 10-Feb-2017
Recent Advances in Colon Targeted Drug Delivery Systems
Presented by- Sulabh SinghaniaM.Pharm – 2nd SEM
DEPARTMENT OF PHARMACEUTICS
Enrollment No-201504100410019
05/01/2023 2
Novel Advancements in CDDSPCDCS.CODESTM.OROS – CT.Pulsincap system.Port system.Time clock system.Hydrophilic sandwich
capsule.
Chronotropic system.Colal – Pred system.Targit technology.Egalet technology.Enterion capsule
technology.
05/01/2023 3
Pressure-Controlled Drug-Delivery Systems(PCDDS)
• Lag time of 3-5 hrs is noted.• Driving force-Peristalsis.• Drug release occurs following disintegration of a water-
insoluble polymer capsule as a result of pressure.
• Thickness of the membrane, capsule size and density plays a crucial role in release.
• Drug delivered should be in liquid state to facilitate absorption as lumen content is already viscous.
05/01/2023 4
CODESTM
05/01/2023 5
CODESTM
• CODESTM is a combined approach of pH dependent and microbially triggered CDDS.
• The premise of the technology is that the enteric coating protects the tablet while it is located in the stomach and then dissolves quickly following gastric emptying.
• The acid soluble material coating then protects the preparation as it passes through the alkaline pH of the small intestine.
05/01/2023 6
CODESTM
• Once the tablet arrives in the colon, the bacteria enzymatically the polysaccharide (lactulose) into organic acid.
• This lowers the pH surrounding the system sufficient to effect the dissolution of the acid soluble coating and subsequent drug release.
05/01/2023 7
Osmotic Controlled Drug Delivery (OROS-CT)
05/01/2023 8
(OROS-CT)
• The OROS-CT system can be a single osmotic unit or may incorporate as many as 5-6 push-pull units, each 4 mm in diameter, encapsulated within a hard gelatin capsule.
• Each bilayer push pull unit contains an osmotic push layer and a drug layer, both surrounded by a semi permeable membrane.
• An orifice(6.35µm) is drilled through the membrane next to the drug layer
05/01/2023 9
(OROS-CT)
• Upon swelling the gelatin capsule dissolves.
• Drug impermeable enteric coating of push pull units prevent it from absorbing water in acidic environment.
• Upon entering small intestine the coating dissolves whereby, allowing absorption of water, causing the osmotic push compartment to swell concomitantly creates a flow-able gel in the drug compartment
05/01/2023 10
(OROS-CT)
• Swelling of the osmotic push compartment forces drug gel out of the orifice at a rate precisely controlled by the rate of water transport through the semi permeable membrane
• Materials used as – semi permeable materials- cellulose acylate, or cellulose
acetate– Osmopolymers- PVA, PVP– Enteric coating materials- pthalates bases.
05/01/2023 11
PULSINCAP System
05/01/2023 12
PULSINCAP System• It comprises of a water-insoluble capsule enclosing the drug
reservoir.• A swellable hydrogel plug was used to seal the drug contents
into the capsule body.• When this capsule came in contact with the dissolution fluid,
it swelled; and after a lag time, the plug pushed itself outside the capsule and rapidly released the drug.
• The length of the plug and its point of insertion into the capsule controlled the lag time.– Polymers for hydrogels –HPMC, PVA, PEO, PMA
05/01/2023 13
Hydrophilic sandwich capsule
• It is simply a capsule in capsule. • Within which the intracellular space is filled with hydrophilic
polymer, which created a hydrophilic sandwich between two capsules.
• When the outer shell dissolved the hydrophilic polymer provided a time delay before the fluid could enter the inner capsule and cause drug release.
• The time delay was controlled by the molecular weight of the polymers and it can also be further manipulated.
05/01/2023 14
PORT system
05/01/2023 15
PORT system
• It consists of a capsule coated with a semipermeable membrane.
• Inside the capsule was an insoluble plug(made up of waxes, fatty easters) consisting of osmotically active agent( mannitol, sorbitol etc,) and the drug formulation.
• The increased pressure due to swelling of osmogen forces the plug to slide out of the shell to release the drug.
05/01/2023 16
TIMECLOCK system
05/01/2023 17
TIMECLOCK system
• Based on solid dosage form that is coated by an aqueous dispersion.
• This coating is a hydrophobic surfactant layer to which a water soluble polymer is added to improve adhesion to the core.
• Upon contact with the dissolution fluid the dispersion rehydrates and redisperses.
• The lag time could be controlled by varying the thickness of the film. After the lag time, i.e; the time required for rehydration, the core immediately releases the drug.
05/01/2023 18
TARGITTM
• It is developed to deliver drugs for the topical treatment of the colonic diseases.
• The technology is based on the application of pH- Sensitive coatings onto injection-moulded starch capsules.
• An extensive body of clinical data has been generated showing reliable in vivo performance of the capsules.
• TARGIT based products are in active clinical development for the treatment of conditions including inflammatory bowel diseases.
05/01/2023 19
Chronotropic system
05/01/2023 20
Chronotropic system
• These systems are based upon a drug reservoir surrounded with a soluble barrier layer that dissolves with time and the drug releases at once after this lag time.
• Chronotropic system consists of a core containing reservoir coated by a hydrophilic polymer HPMC.
• An additional enteric-coated film is given outside this layer to overcome intra subject variability in gastric emptying rates
• The lag time and the onset of action are controlled by the thickness and the viscosity grade of HPMC.
05/01/2023 21
Enterion capsule Technology• Long, round-ended capsule and contains a drug reservoir with
a volume capacity of approximately 1 ml. • The capsule can be loaded with either a liquid formulation
through an opening 9 mm in diameter, which is then sealed by inserting a push-on Cap fitted with a silicone O-ring.
• A radioactive marker is placed inside a separate sealed tracer port to allow real time visualization of the capsule location using the imaging technique of gamma Scintigraphy.
• Upon reaching the target site in GI tract, the contents are actively ejected by the external application of an oscillating magnetic field.
05/01/2023 22
COLALTM
• COLAL-PRED has a coating that is broken down only in the colon, by locally occurring bacteria.
• COLAL-PRED is a proprietary gastrointestinal product developed by alizyme for the treatment of ulcerative colitis (US).
• This leads to topical delivery of prednisolone to the colon without significant systemic exposure so minimizing steroid related side effects.
• It is ethyl-cellulose and amylase film coating based system, in which amylase works in pore forming agent and EC act as release control matrix agent via swelling or enzyametic degradation.
05/01/2023 23
EGALET TECHNOLOGY
• It offers two systems the constant release 2K system and delayed release 3K system.
• The 2K system consists of two compartments: an impermeable coat and matrix.
• The drug is distributed throughout the matrix and it release the drug as it passes through the gut.
05/01/2023 24
EGALET TECHNOLOGY
• The 3K comprises of impermeable shell and two lag plugs. • Enclosing the active drug into two lags.
• The active drug releases after the lags are removed causing a delay in the drug release.
05/01/2023 25
References
• K.V. Vinaykumar et al. “Colon targeting drug delivery system: A review on recent approaches. Int J Pharm Biomed Sci 2011.
• R.J. Michael et al. modified release drug delivery system, informa healthcare volume 1 second edition P.No. 287-356.
05/01/2023 26
THANK YOU